Deceased-donor apolipoprotein L1 renal-risk variants have minimal effects on liver transplant outcomes

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Dorr, Casey R ^a,b   Freedman, Barry I ^c   Hicks, Pamela J ^c   Brown, W Mark ^c   Russell, Gregory B ^c   Julian, Bruce A ^d   Pastan, Stephen O ^e   Gautreaux, Michael D ^c   Muthusamy, Amutha ^a   Chinnakotla, Srinath ^b   Hauptfeld, Vera ^f   Bray, Robert A ^e   Kirk, Allan D ^g   Divers, Jasmin ^c   Israni, Ajay K ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d University of Alabama at Birmingham   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L1; UNCLASSIFIED DRUG; APOL1 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN;

ADULT; AFRICAN AMERICAN; ALLELE; APOL1 GENE; ARTICLE; CONTROLLED STUDY; DONOR; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; LIVER GRAFT; MALE; RISK; ALLOGRAFT; CLINICAL TRIAL; GENETICS; LIVER TRANSPLANTATION; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; ALLOGRAFTS; APOLIPOPROTEINS; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SURVIVAL RATE; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84963490926     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152775     Document Type: Article

References (22)

1. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, et al. The APOL1 gene and allograft survival after kidney transplantation. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2011) 11: 1025-1030.
2. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Human genetics (2010) 128: 345-350. doi: 10.1007/s00439-010-0861-0 PMID: 20635188.
3. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 329: 841-845. doi: 10.1126/science.1193032 PMID: 20647424.
4. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, et al. Apolipoprotein L1 Gene Variants in Deceased Organ Donors Are Associated With Renal Allograft Failure. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2015).
5. Tayo BO, Kramer H, Salako BL, Gottesman O, McKenzie CA, Ogunniyi A, et al. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians. International urology and nephrology (2013) 45: 485-494. doi: 10.1007/s11255-012-0263-4 PMID: 22956460.
6. Limou S, Nelson GW, Kopp JB, Winkler CA APOL1 kidney risk alleles: population genetics and disease associations. Advances in chronic kidney disease (2014) 21: 426-433. doi: 10.1053/j.ackd.2014.06.005 PMID: 25168832.
7. Ito K, Bick AG, Flannick J, Friedman DJ, Genovese G, Parfenov MG, et al. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants. Circulation research (2014) 114: 845-850. doi: 10.1161/CIRCRESAHA.114.302347 PMID: 24379297.
8. Freedman BI, Langefeld CD, Lu L, Palmer ND, Smith SC, Bagwell BM, et al. APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes. Kidney international (2015) 87: 176-181. doi: 10.1038/ki.2014.255 PMID: 25054777.
9. Duchateau PN, Pullinger CR, Cho MH, Eng C, Kane JP Apolipoprotein L gene family: Tissue-specific expression, splicing, promoter regions; discovery of a new gene. Journal of lipid research (2001) 42: 620-630. PMID: 11290834.
10. Duchateau PN, Movsesyan I, Yamashita S, Sakai N, Hirano K, Schoenhaus SA, et al. Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. Journal of lipid research (2000) 41: 1231-1236. PMID: 10946010.
11. Nichols B, Jog P, Lee JH, Blackler D, Wilmot M, D'Agati V, et al. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney international (2015) 87: 332-342. doi: 10.1038/ki.2014.270 PMID: 25100047.
12. Thomson R, Genovese G, Canon C, Kovacsics D, Higgins MK, Carrington M, et al. Evolution of the primate trypanolytic factor APOL1. Proceedings of the National Academy of Sciences of the United States of America (2014) 111: E2130-E2139. doi: 10.1073/pnas.1400699111 PMID: 24808134.
13. Gangadharan B, Antrobus R, Dwek RA, Zitzmann N, Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clinical chemistry (2007) 53: 1792-1799. PMID: 17702858.
14. Cheng D, Weckerle A, Yu Y, Ma L, Zhu X, Murea M, et al. Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells. Journal of lipid research (2015) 56: 1583- 1593. doi: 10.1194/jlr.M059733 PMID: 26089538.
15. Oetting WS, Guan W, Schladt DP, Leduc RE, Jacobson PA, Matas AJ, et al. Donor polymorphisms of toll-like receptor 4 associated with graft failure in liver transplant recipients. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2012) 18: 1399-1405.
16. Israni AK, Zaun DA, Rosendale JD, Snyder JJ, Kasiske BL OPTN/SRTR 2013 Annual Data Report: deceased organ donation. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2015) 15 Suppl 2: 1-13.
17. Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, et al. OPTN/SRTR 2013 Annual Data Report: liver. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2015) 15 Suppl 2: 1-28.
18. Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. The Journal of clinical investigation (2005) 115: 1333-1342. PMID: 15841208.
19. Ma L, Shelness GS, Snipes JA, Murea M, Antinozzi PA, Cheng D, et al. Localization of APOL1 Protein and mRNA in the Human Kidney: Nondiseased Tissue, Primary Cells, and Immortalized Cell Lines. Journal of the American Society of Nephrology: JASN (2015) 26: 339-348. doi: 10.1681/ASN.2013091017 PMID: 25012173.
20. Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Hu CA Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. The Journal of biological chemistry (2008) 283: 21540-21549. doi: 10.1074/jbc.M800214200 PMID: 18505729.
21. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, et al. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation (2016) 100: 194-202. doi: 10.1097/TP.0000000000000969PMID: 26566060.
22. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, et al. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2015) 15: 1615-1622.